These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 27770778
21. Under sevoflurane anaesthesia, a reduced dose of neostigmine can antagonize a shallow neuromuscular block: A double-blind, randomised study. Preault A, Capron F, Chantereau C, Donati F, Dimet J. Anaesth Crit Care Pain Med; 2016 Aug; 35(4):269-73. PubMed ID: 27131419 [Abstract] [Full Text] [Related]
24. Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns. Bash LD, Black W, Turzhitsky V, Urman RD. Anesth Analg; 2021 Dec 01; 133(6):1437-1450. PubMed ID: 34784330 [Abstract] [Full Text] [Related]
25. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings. Bash LD, Turzhitsky V, Black W, Urman RD. Adv Ther; 2021 Sep 01; 38(9):4736-4755. PubMed ID: 34319550 [Abstract] [Full Text] [Related]
28. Pharmacokinetics of Sugammadex Dosed by Actual and Ideal Body Weight in Patients With Morbid Obesity Undergoing Surgery. Mostoller K, Wrishko R, Maganti L, Herring WJ, van Zutphen-van Geffen M. Clin Transl Sci; 2021 Mar 01; 14(2):737-744. PubMed ID: 33278332 [Abstract] [Full Text] [Related]
32. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery. Rahe-Meyer N, Berger C, Wittmann M, Solomon C, Abels EA, Rietbergen H, Reuter DA. Anaesthesist; 2015 Jul 01; 64(7):506-12. PubMed ID: 26126940 [Abstract] [Full Text] [Related]
33. Neostigmine requirements for reversal of neuromuscular blockade following an infusion of mivacurium. Lessard MR, Trépanier CA, Rouillard JF. Can J Anaesth; 1997 Aug 01; 44(8):836-42. PubMed ID: 9260011 [Abstract] [Full Text] [Related]
34. Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function. Lederer W, Reiner T, Khuenl-Brady KS. J Clin Anesth; 2010 Sep 01; 22(6):420-4. PubMed ID: 20868962 [Abstract] [Full Text] [Related]
35. The Safety of Neuromuscular Blockade Reversal in Patients With Cardiac Transplantation. Barbara DW, Christensen JM, Mauermann WJ, Dearani JA, Hyder JA. Transplantation; 2016 Dec 01; 100(12):2723-2728. PubMed ID: 26760570 [Abstract] [Full Text] [Related]
38. Intermediate-Acting Nondepolarizing Neuromuscular Blocking Agents and Risk of Postoperative 30-Day Morbidity and Mortality, and Long-term Survival. Bronsert MR, Henderson WG, Monk TG, Richman JS, Nguyen JD, Sum-Ping JT, Mangione MP, Higley B, Hammermeister KE. Anesth Analg; 2017 May 01; 124(5):1476-1483. PubMed ID: 28244947 [Abstract] [Full Text] [Related]
39. Effect of coadministration of 10 mg/kg calcium chloride and neostigmine on extubation time: A randomized controlled trial. Elkenany S, Alseoudy MM, Elshehawi ME, Bakrey S, Aboelela M. Rev Esp Anestesiol Reanim (Engl Ed); 2024 May 01; 71(6):438-444. PubMed ID: 38615713 [Abstract] [Full Text] [Related]
40. Risk factors for administration of additional reversal following neuromuscular blockade with rocuronium in children: A retrospective case-control study. Vishneski SR, Saha AK, Fram MR, Templeton LB, Lee LK, Ririe DG, Goenaga-Diaz EJ, Smith LD, Templeton TW. Paediatr Anaesth; 2022 Aug 01; 32(8):916-925. PubMed ID: 35438816 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]